Merosin-negative congenital muscular dystrophy is a rare genetic disease of childhood involving the central and peripheral nervous system. There were high signal intensities throughout the centrum semiovale, periventricular, and sub-cortical white matters on T2-weighted images in a 4-year-old girl with merosin-negative congenital muscular dystrophy. An apparent diffusion coefficient map revealed increased signal intensity and apparent diffusion coefficient values in the periventricular and deep white matters. It may be attributable to increased water content in the white matter because of an abnormal blood-brain barrier rather than to decreased or abnormal myelination.
Echenne B., Rivier F., Jellali AJ, et al. Merosin positive congenital muscular dystrophy with mental deficiency, epilepsy and MRI changes in the cerebral white matter. Neuromuscul Disord. 1997; 7:187-190.
2.
Farina L., Morandi L., Milanesi I., et al. Congenital muscular dystrophy with merosin deficiency: MRI findings in five patients. Neuroradiology. 1998;40:807-811.
3.
Gilhuis HJ, ten Donkelaar HJ, Tanke RB, et al. Nonmuscular involvement in merosin-negative congenital muscular dystrophy. Pediatr Neurol.2002;26:30-36.
4.
van der Knaap MS, Smit LM, Barth PG, et al. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol.1997;42:50-59.
5.
Echenne B., Pages M., Marty-Double C.Congenital muscular dystrophy with cerebral white matter spongiosis. Brain Dev.1984;6:491-495.
6.
Schaefer PW, Grant PE, Gonzalez RGDiffusion-weighted MR imaging of the brain. Radiology. 2000;217:331-345.
7.
Leite CC, Reed UC, Otaduy MC, et al. Congenital muscular dystrophy with merosin deficiency: 1H MR spectroscopy and diffusion-weighted MR imaging. Radiology . 2005;235:190-196.
8.
Matsumura K., Yamada H., Saito F., et al. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromuscul Disord. 1997;7:7-12.
9.
Villanova M., Malandrini A., Toti P., et al. Localization of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicrosc Cytol Pathol. 1996;28:1-4.
10.
Philpot J., Cowan F., Pennock J., et al. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul Disord. 1999;9: 81-85.
11.
Caro PA, Scavina M., Hoffman E., et al. MR imaging findings in children with merosin-deficient congenital muscular dystrophy. AJNR Am J Neuroradiol.1999;20:324-326.
12.
Villanova M. , Sewry C., Malandrini A., et al. Immunolocalization of several laminin chains in the normal human central and peripheral nervous system. J Submicrosc Cytol Pathol. 1997;29:409-413.
13.
Mercuri E., Pennock J., Goodwin F., et al. Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy. Neuromuscul Disord. 1996;6:425-429.
14.
Trevisan CP , Martinello F., Ferruzza E., et al. Brain alterations in the classical form of congenital muscular dystrophy: clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle. Childs Nerv Syst.1996;12: 604-610.
